These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16037288)

  • 21. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics.
    Schmitt A; Schmitt J; Münch G; Gasic-Milencovic J
    Anal Biochem; 2005 Mar; 338(2):201-15. PubMed ID: 15745740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end products in renal failure: an overview.
    Noordzij MJ; Lefrandt JD; Smit AJ
    J Ren Care; 2008 Dec; 34(4):207-12. PubMed ID: 19090900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
    Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
    Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
    Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
    Nienhuis HL; de Leeuw K; Bijzet J; Smit A; Schalkwijk CG; Graaff R; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2008 Oct; 47(10):1554-8. PubMed ID: 18701539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometry to detect the site specificity of advanced glycation/lipoxidation end-product formation on protein: some challenges and solutions.
    Ames JM
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):1051-4. PubMed ID: 18793187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases.
    Saito A; Takeda T; Sato K; Hama H; Tanuma A; Kaseda R; Suzuki Y; Gejyo F
    Ann N Y Acad Sci; 2005 Jun; 1043():637-43. PubMed ID: 16037287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of muscle protein in diabetes.
    Alt N; Carson JA; Alderson NL; Wang Y; Nagai R; Henle T; Thorpe SR; Baynes JW
    Arch Biochem Biophys; 2004 May; 425(2):200-6. PubMed ID: 15111128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production.
    McCarty MF
    Med Hypotheses; 2005; 64(2):394-8. PubMed ID: 15607576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of elevated N epsilon-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia.
    Rüster M; Franke S; Späth M; Pongratz DE; Stein G; Hein GE
    Scand J Rheumatol; 2005; 34(6):460-3. PubMed ID: 16393769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end product free adducts are cleared by dialysis.
    Agalou S; Ahmed N; Thornalley PJ; Dawnay A
    Ann N Y Acad Sci; 2005 Jun; 1043():734-9. PubMed ID: 16037300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of N epsilon-(carboxymethyl)lysine in exhaled breath condensate using isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry.
    Gonzalez-Reche LM; Kucharczyk A; Musiol AK; Kraus T
    Rapid Commun Mass Spectrom; 2006; 20(18):2747-52. PubMed ID: 16921564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.